Table 4. Appropriateness of DOACs prescriptions.
Legend:C-Gault, Cockcroft-Gault; GFR, glomerular filtration rate; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PO, per os; BID, twice a day; QD, once a day
| Criteria | Appropriateness, n (%) | 95% CI | |
| 1. Type of AF | Appropriate use | 487/500 (97.4) | 96.0 - 98.8 |
| 2. Mitral stenosis | Appropriate use | 495/500 (99.0) | 98.1 - 99.9 |
| 3. CHADS2 score CHADS2 > 1 CHADS2 = 0 | Appropriate use Appropriate use Total number of appropriate use | 473/473 (100.0) 13/27 (48.1) 486/500 (97.2) | 95.8 - 98.7 |
| 4. Heart valves | Appropriate use | 500/500 (100.0) | |
| 5. Concomitant medication | Appropriate use | 500/500 (100.0) | |
| 6. Renal function | |||
| Dabigatran and rivaroxaban Apixaban | Appropriate use Appropriate use Total number of appropriate use | 446/457 (97.6) 43/43 (100.0) 489/500 (97.8) | 96.5 - 99.0 |
| 7. Liver enzymes levels | Appropriate use | 395/407 (97.1) | 95.4 - 98.7 |
| 8. a. Dose of dabigatran | |||
| Dabigatran 110 mg BID Dabigatran 150 mg BID | Appropriate use Appropriate use Total number of appropriate use | 106/130 (81.5) 67/105 (63.8) 173/235 (73.6) | 67.9 - 79.3 |
| 8. b. Dose of rivaroxaban | |||
| Rivaroxaban 15 mg DIE Rivaroxaban 20 mg DIE | Appropriate use Appropriate use Total number of appropriate use | 31/61 (50.8) 148/161 (91.9) 179/222 (80.6) | 75.4 - 85.9 |
| 8. c. Dose of apixaban Apixaban 2,5 mg BID, Apixaban 5 mg BID , | Appropriate use, Appropriate use, Total number of appropriate use | 7/20 (35.0) 23/23 (100.0) 30/43 (69.8) | 55.5 - 84.1 |
| Overall appropriateness | Appropriate use | 352/500 (70.4) | 66.4 - 74.4 |